Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17880360 | 0.85 | ALDH1A1 (0.53) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL17880355 | 0.84 | ALDH1A1 (0.41) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL17880354 | 0.76 | ALDH1A1 (0.31) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL17880367 | 0.76 | CYP1A2 (0.35) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL28132984 | 0.73 | ALDH1A1 (0.55) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| Toluene SCHEMBL28132983 | 0.72 | TSHR (0.46) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL15497853 | 0.72 | ALDH1A1 (0.61) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL25639338 | 0.71 | HSD17B10 (0.52) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL25639351 | 0.71 | HSD17B10 (0.52) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL1062422 | 0.71 | CYP1A2 (0.39) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793063-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11793063-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-20160190450-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160190450-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793063-B2 | Condensed-cyclic compound and organic light emitting device including the same | CRY1, CRY2, CCNE2 | ALDH1A1 518/4885CYP3A4 1257/4885HPGD 1827/4885 |
| US-20160190450-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | ALDH1A1 518/4885CYP3A4 1257/4885HPGD 1827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.